Literature DB >> 422234

Interactions between human granulocytes and Blastomyces dermatitidis.

J W Sixbey, B T Fields, C N Sun, R A Clark, C M Nolan.   

Abstract

We studied interactions in vitro between human granulocytes and the yeast-like form of Blastomyces dermatitidis, because granulocytes are prominent in the host response to systemic blastomycosis. In Boyden chamber assays, broth culture filtrates of B. dermatitidis contained levels of granulocyte chemotactic activity that were significantly higher than those present in similar culture filtrates of Histoplasma capsulatum and Cryptococcus neoformans, two fungi that characteristically do not elicit granulocytes in infected tissues. Microscopic study, including electron microscopy, demonstrated that granulocytes phagocytosed B. dermatitidis promptly and efficiently. Moreover, granulocytes emitted light (chemiluminescence) at a brisk rate during phagocytosis of B. dermatitidis, indicating activation of intracellular metabolic pathways. However, fungicidal assay showed that granulocytes (1:1 cell-yeast ratio, 10% serum) killed only 29% of the B. dermatitidis inoculum during 3 h of incubation. Taken together, these findings suggest that there is disparity between phagocytosis and intracellular killing of B. dermatitidis by human granulocytes, perhaps because of resistance of this fungus to granulocyte microbicidal mechanisms.

Entities:  

Mesh:

Year:  1979        PMID: 422234      PMCID: PMC550686          DOI: 10.1128/iai.23.1.41-44.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Phagocytosis of yeast cells in vitro.

Authors:  C J WANG; J SCHWARZ
Journal:  Am J Pathol       Date:  1959 Jul-Aug       Impact factor: 4.307

2.  Bacterial factors chemotactic for polymorphonuclear leukocytes.

Authors:  P A Ward; I H Lepow; L J Newman
Journal:  Am J Pathol       Date:  1968-04       Impact factor: 4.307

3.  Histochemistry and electron microscopy of the renal papilla in a genetic strain of rats with diabetes insipidus.

Authors:  C N Sun; H J White; E J Towbin
Journal:  Nephron       Date:  1972       Impact factor: 2.847

4.  The origin of the chemiluminescence of phagocytosing granulocytes.

Authors:  B D Cheson; R L Christensen; R Sperling; B E Kohler; B M Babior
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

5.  Mechanisms of attachment of neutrophils to Candida albicans pseudohyphae in the absence of serum, and of subsequent damage to pseudohyphae by microbicidal processes of neutrophils in vitro.

Authors:  R D Daimond; R Krzesicki
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

6.  Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro.

Authors:  R D Diamond; R Krzesicki; W Jao
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

7.  Effect of chemoattractants on chemiluminescence.

Authors:  C D Allred; H R Hill
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

8.  Chemotactic factor produced by Candida albicans.

Authors:  J E Cutler
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

9.  Functional aspects of a second mechanism of candidacidal activity by human neutrophils.

Authors:  R I Lehrer
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

10.  Quantitative granulocyte chemiluminescence in the rapid detection of impaired opsonization of Escherichia coli.

Authors:  P Stevens; L S Young
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

View more
  15 in total

1.  Miliary blastomycosis and HIV infection.

Authors:  A M Herd; S B Greenfield; G W Thompson; R C Brunham
Journal:  CMAJ       Date:  1990-12-15       Impact factor: 8.262

2.  Mechanisms of fungal pathogenicity: correlation of virulence in vivo, susceptibility to killing by polymorphonuclear neutrophils in vitro, and neutrophil superoxide anion induction among Blastomyces dermatitidis isolates.

Authors:  C J Morrison; D A Stevens
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

3.  Blastomyces dermatitidis serine protease dipeptidyl peptidase IVA (DppIVA) cleaves ELR+ CXC chemokines altering their effects on neutrophils.

Authors:  Jenna Lorenzini; J Scott Fites; Jeniel Nett; Bruce S Klein
Journal:  Cell Microbiol       Date:  2017-05-30       Impact factor: 3.715

4.  In vitro susceptibility of fungi to killing by neutrophil granulocytes discriminates between primary pathogenicity and opportunism.

Authors:  A Schaffner; C E Davis; T Schaffner; M Markert; H Douglas; A I Braude
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

5.  Host defence to pulmonary mycosis.

Authors:  C H Mody; P W Warren
Journal:  Can J Infect Dis       Date:  1999-03

6.  Blastomyces dermatitidis chemotactic factor: kinetics of production and biological characterization evaluated by a modified neutrophil chemotaxis assay.

Authors:  L M Thurmond; T G Mitchell
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

7.  New method for estimating digestion of Paracoccidioides brasiliensis by phagocytic cells in vitro.

Authors:  M Goihman-Yahr; E Essenfeld-Yahr; M C Albornoz; L Yarzábal; M H de Gómez; B San Martín; A Ocanto; J Convit
Journal:  J Clin Microbiol       Date:  1979-09       Impact factor: 5.948

Review 8.  An overview of macrophage-fungal interactions.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1986-02       Impact factor: 2.574

9.  Enhancing effect of murine polymorphonuclear neutrophils (PMN) on the multiplication of Blastomyces dermatitidis in vitro and in vivo.

Authors:  E Brummer; D A Stevens
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

10.  Granuloma formation and killing functions of granuloma in congenitally athymic nude mice infected with Blastomyces dermatitidis and Paracoccidioides brasiliensis.

Authors:  M Miyaji; K Nishimura
Journal:  Mycopathologia       Date:  1983-06-20       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.